Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
NCT Number: NCT03467893
Proton pump inhibitor are frequently used and are short term well tolerated ; but few studies show there are adverse event in long term prescription like fracture or pulmonary infection to Clostridum difficile. The fact is that multi medication in old patient increase the iatrogenic risk and decrease the medication compliance. The Proton pump inhibitor (PPI)are overused in this patient category.Several studies suggest the existence of a rebound effect when people were treated more than 8 weeks ; this effect seems to appear around 14 days after with hyperacidity symptoms.
But there are no studies about old patient. So in this context the aim of the study is to evaluate the prevalence of rebound effect occurence after the end of PPI 8 weeks treatment.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Paris, Île-de-France Region, 75014, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
number aof antacids treatment after PPI stop
Time frame: Day 14 after end of treatment
Fondation Hôpital Saint-Joseph
Other
Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor After 8 Weeks of Treatment in Geriatric Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06778395
Deglutition Disorders, Digestive System Diseases
Zagazig, Sharqia Province, Egypt
View Trial DetailsNCT04637750
Primary Care, Proton Pump Inhibitor
Sesto San Giovanni, Milan, Italy
View Trial DetailsNCT05348252
Discontinuation, E-health
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT05533619
Acute Kidney Injury, Female Urogenital Diseases
Jinan, Shandong, China
View Trial Details